Differences in Metabolic Factors Between Antipsychotic-Induced Weight Gain and Non-pharmacological Obesity in Youths

Different Immune Signature in Youths Experiencing Antipsychotic-Induced Weight Gain Compared to Untreated Obese Patients

(2017) Simone Pisano et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Childhood predictors of cardiovascular disease in adulthood. A systematic review and meta-analysis

(2017) O. Ajala et al.   Obesity Reviews

Cross Talk: The Microbiota and Neurodevelopmental Disorders

(2017) John R. Kelly et al.   Frontiers in Neuroscience

A Practical Review of C-Peptide Testing in Diabetes

(2017) Emma Leighton et al.   Diabetes Therapy

A Practical Review of C-Peptide Testing in Diabetes

(2017) Emma Leighton et al.   Diabetes Therapy

The effects of antipsychotics on weight gain, weight-related hormones and homocysteine in children and adolescents: a 1-year follow-up study

(2016) Inmaculada Baeza et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Second generation antipsychotics in ‘real-life’ paediatric patients. Adverse drug reactions and clinical outcomes of drug switch

(2016) Concetta Rafaniello et al.   Expert Opinion On Drug Safety

Persistence in Therapy With Risperidone and Aripiprazole in Pediatric Outpatients

(2016) Marco Pozzi et al.   JOURNAL OF CLINICAL PSYCHIATRY

Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics

(2016) Britta Galling et al.   JAMA Psychiatry

Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings

(2015) Marco Pozzi et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Efficacy and Safety of Risperidone and Quetiapine in Adolescents With Bipolar II Disorder Comorbid With Conduct Disorder

(2015) Gabriele Masi et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Plasma adiponectin levels in schizophrenia and role of second-generation antipsychotics: A meta-analysis

(2015) Francesco Bartoli et al.   PSYCHONEUROENDOCRINOLOGY

Use of Quetiapine in Children and Adolescents

(2015) Gabriele Masi et al.   PEDIATRIC DRUGS

Treatment of Young People With Antipsychotic Medications in the United States

(2015) Mark Olfson et al.   JAMA Psychiatry

Use of the second-generation antipsychotic, risperidone and secondary weight gain are associated with an altered gut microbiota in children

(2015) S M Bahr et al.   Translational Psychiatry

Adipsin Is an Adipokine that Improves β Cell Function in Diabetes

(2014) James C. Lo et al.   CELL

Glucometabolic Hormones and Cardiovascular Risk Markers in Antipsychotic-Treated Patients

(2014) Bjørn H. Ebdrup et al.   JOURNAL OF CLINICAL PSYCHIATRY

Antipsychotic-Induced Dyslipidemia Treated with Omega 3 Fatty Acid Supplement in an 11-Year-Old Psychotic Child: A 1-Year Follow-up

(2013) Simone Pisano et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Microbiota and Gut–Liver Axis

(2013) Pietro Vajro et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Comparison of Long-Term (At Least 24 Weeks) Weight Gain and Metabolic Changes Between Adolescents and Adults Treated with Olanzapine

(2012) Ludmila A. Kryzhanovskaya et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

(2009) Christoph U. Correll   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin

(2008) Hua Jin et al.   SCHIZOPHRENIA RESEARCH